0001140361-17-034317.txt : 20170905 0001140361-17-034317.hdr.sgml : 20170904 20170905165051 ACCESSION NUMBER: 0001140361-17-034317 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170831 FILED AS OF DATE: 20170905 DATE AS OF CHANGE: 20170905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hershberger Michael D CENTRAL INDEX KEY: 0001569128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35811 FILM NUMBER: 171069278 MAIL ADDRESS: STREET 1: C/O HEALTH INSURANCE INNOVATIONS, INC. STREET 2: 15438 N. FLORIDA AVENUE, SUITE 201 CITY: TAMPA STATE: FL ZIP: 33613 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Health Insurance Innovations, Inc. CENTRAL INDEX KEY: 0001561387 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 461282634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15438 N. FLORIDA AVENUE STREET 2: SUITE 201 CITY: TAMPA STATE: FL ZIP: 33613 BUSINESS PHONE: 813-397-1187 MAIL ADDRESS: STREET 1: 15438 N. FLORIDA AVENUE STREET 2: SUITE 201 CITY: TAMPA STATE: FL ZIP: 33613 4 1 doc1.xml FORM 4 X0306 4 2017-08-31 0 0001561387 Health Insurance Innovations, Inc. HIIQ 0001569128 Hershberger Michael D C/O HEALTH INSURANCE INNOVATIONS, INC. 15438 NORTH FLORIDA AVE., SUITE 201 TAMPA FL 33613 0 1 0 0 CFO, Secretary and Treasurer Class A Common Stock 2017-08-31 4 S 0 2500 34.8066 D 94569 D Class A Common Stock 2017-09-01 4 S 0 400 28.3625 D 94169 D Class A Common Stock 2017-09-01 4 S 0 3300 29.0990 D 90869 D Class A Common Stock 2017-09-01 4 S 0 100 30.45 D 90769 D Class A Common Stock 2017-09-01 4 S 0 800 32.0875 D 89969 D Class A Common Stock 2017-09-01 4 S 0 400 33.7375 D 89569 D Class A Common Stock 2017-09-01 4 M 0 15000 10.45 A 104569 D Class A Common Stock 2017-09-01 4 D 0 4659 28.965 D 99910 D Class A Common Stock 2017-09-01 4 S 0 3597 28.965 D 96313 D Class A Common Stock 2017-09-01 4 M 0 15000 4.95 A 111313 D Class A Common Stock 2017-09-01 4 D 0 2207 32.0163 D 109106 D Class A Common Stock 2017-09-01 4 S 0 4450 32.0163 D 104656 D Class A Common Stock 2017-09-01 4 M 0 7500 4.99 A 112156 D Class A Common Stock 2017-09-01 4 D 0 1113 33.8103 D 111043 D Class A Common Stock 2017-09-01 4 S 0 2222 33.8103 D 108821 D Stock Appreciation Rights 10.45 2017-09-01 4 M 0 15000 0 D 2021-05-21 Common Stock 15000 10000 D Stock Appreciation Rights 4.95 2017-09-01 4 M 0 15000 0 D 2022-07-01 Common Stock 15000 15000 D Stock Appreciation Rights 4.99 2017-09-01 4 M 0 7500 0 D 2022-09-16 Common Stock 7500 22500 D Stock Appreciation RIghts 5.2 2023-09-16 Common Stock 40972 40972 D The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.75 to $34.90, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Sale made pursuant to 10b5-1 plan executed on November 18, 2016. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.85 to $28.70, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.0990, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.90 to $32.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.65 to $33.80, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. These stock-settled stock appreciation rights were granted under the Long Term Incentive Plan of Health Insurance Innovations, Inc. (the "Plan") and vest 20% on the first three anniversaries of grant date and 40% on the fourth anniversary, subject to the terms of the Plan and an award agreement under the Plan. These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first and second anniversaries of grant date and 50% on the third anniversary, subject to the terms of the Plan and an award agreement under the Plan. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.90 to $29.00, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.15, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.80 to $33.90, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person. /s/ Michael D. Hershberger 2017-09-05